389 related articles for article (PubMed ID: 33045338)
1. Ultrastructural changes caused by the combination of intravenous immunoglobulin with meropenem, amikacin and colistin in multidrug-resistant Acinetobacter baumannii.
Lima FCG; Oliveira-Júnior JB; Cavalcanti CLB; Veras DL; Freitas CF; Sandes JM; da Silva EM; da Rocha DAM; Alves LC; Brayner FA
Microb Pathog; 2020 Dec; 149():104437. PubMed ID: 33045338
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of human intravenous immunoglobulin in combination with antimicrobials and human serum against multidrug-resistant isolates of Acinetobacter baumannii.
de Lima FCG; de Araújo AR; do Nascimento AV; Bezerra Cavalcanti CL; Oliveira Júnior JB; Sandes JM; da Silva EM; de Freitas CF; Veras DL; Alves LC; Brayner FA
Braz J Microbiol; 2023 Dec; 54(4):2845-2856. PubMed ID: 37904004
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of synergistic activity of antibiotic combinations in extensive drug-resistant
Abdel Halim RM; Saber SM; Fahim NAE
J Med Microbiol; 2023 Feb; 72(2):. PubMed ID: 36762530
[No Abstract] [Full Text] [Related]
6. Effect of combined colistin and meropenem against meropenem resistant
Gunalan A; Sarumathi D; Sastry AS; Ramanathan V; Rajaa S; Sistla S
Indian J Pharmacol; 2021; 53(3):207-212. PubMed ID: 34169905
[TBL] [Abstract][Full Text] [Related]
7.
Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
[TBL] [Abstract][Full Text] [Related]
8. A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii.
Marie MA; Krishnappa LG; Alzahrani AJ; Mubaraki MA; Alyousef AA
Bosn J Basic Med Sci; 2015 Oct; 15(4):24-9. PubMed ID: 26614848
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.
Principe L; D'Arezzo S; Capone A; Petrosillo N; Visca P
Ann Clin Microbiol Antimicrob; 2009 May; 8():18. PubMed ID: 19460166
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of ceftazidime/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates.
Mataracı Kara E; Yılmaz M; Özbek Çelik B
J Glob Antimicrob Resist; 2019 Jun; 17():137-141. PubMed ID: 30576787
[TBL] [Abstract][Full Text] [Related]
11. Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an
Bian X; Liu X; Chen Y; Chen D; Li J; Zhang J
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745385
[TBL] [Abstract][Full Text] [Related]
12. In vitro synergistic effect of colistin and ampicillin/sulbactam with several antibiotics against clinical strains of multi-drug resistant Acinetobacter baumannii.
Shafiee F; Naji Esfahani SS; Hakamifard A; Soltani R
Indian J Med Microbiol; 2021 Jul; 39(3):358-362. PubMed ID: 33906750
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo efficacy of cefiderocol plus tigecycline, colistin, or meropenem against carbapenem-resistant Acinetobacter baumannii.
Ni W; Wang Y; Ma X; He Y; Zhao J; Guan J; Li Y; Gao Z
Eur J Clin Microbiol Infect Dis; 2022 Dec; 41(12):1451-1457. PubMed ID: 36201141
[TBL] [Abstract][Full Text] [Related]
14. Synergistic activities of colistin combined with other antimicrobial agents against colistin-resistant Acinetobacter baumannii clinical isolates.
Almutairi MM
PLoS One; 2022; 17(7):e0270908. PubMed ID: 35830449
[TBL] [Abstract][Full Text] [Related]
15. Isothermal microcalorimetry vs checkerboard assay to evaluate in-vitro synergism of meropenem-amikacin and meropenem-colistin combinations against multi-drug-resistant Gram-negative pathogens.
Antonelli A; Coppi M; Tellapragada C; Hasan B; Maruri A; Gijón D; Morecchiato F; de Vogel C; Verbon A; van Wamel W; Kragh KN; Frimodt-Møller N; Cantón R; Giske CG; Rossolini GM
Int J Antimicrob Agents; 2022 Oct; 60(4):106668. PubMed ID: 36038097
[TBL] [Abstract][Full Text] [Related]
16. In Vitro antibiotic combinations of Colistin, Meropenem, Amikacin, and Amoxicillin/clavulanate against multidrug-resistant Klebsiella pneumonia isolated from patients with ventilator-associated pneumonia.
Bayatinejad G; Salehi M; Beigverdi R; Halimi S; Emaneini M; Jabalameli F
BMC Microbiol; 2023 Oct; 23(1):298. PubMed ID: 37864176
[TBL] [Abstract][Full Text] [Related]
17. Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii.
Kamoshida G; Yamada N; Nakamura T; Yamaguchi D; Kai D; Yamashita M; Hayashi C; Kanda N; Sakaguchi M; Morimoto H; Sawada T; Okada T; Kaya Y; Takemoto N; Yahiro K
Microbiol Spectr; 2022 Oct; 10(5):e0192822. PubMed ID: 36173297
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli.
Wang Y; Li H; Xie X; Wu X; Li X; Zhao Z; Luo S; Wan Z; Liu J; Fu L; Li X
J Glob Antimicrob Resist; 2020 Mar; 20():351-359. PubMed ID: 31557565
[TBL] [Abstract][Full Text] [Related]
19. The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.
Ceccarelli G; Oliva A; d'Ettorre G; D'Abramo A; Caresta E; Barbara CS; Mascellino MT; Papoff P; Moretti C; Vullo V; Visca P; Venditti M
BMC Infect Dis; 2015 Sep; 15():393. PubMed ID: 26424078
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece.
Galani I; Souli M; Katsala D; Karaiskos I; Giamarellou H; Antoniadou A
J Antimicrob Chemother; 2024 May; 79(5):1101-1108. PubMed ID: 38501368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
